The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Regulation and Function of the Interleukin 13 Receptor α 2 During a T Helper Cell Type 2–dominant Immune Response
Open accessAbstract
Highly polarized type 2 cytokine responses can be harmful and even lethal to the host if they are too vigorous or persist too long. Therefore, it is important to elucidate the mechanisms that down-regulate these reactions. Interleukin (IL)-13 has emerged as a central mediator of T helper cell (Th)2-dominant immune responses, exhibiting a diverse array of functional activities including regulation of airway hyperreactivity, resistance to nematode parasites, and tissue remodeling and fibrosis. Here, we show that IL-13 receptor (R)α2 is a critical down-regulatory factor of IL-13–mediated tissue fibrosis induced by the parasitic helminth Schistosoma mansoni. IL-13Rα2 expression was induced after the onset of the fibrotic response, IL-10, IL-13, and Stat6 dependent, and inhibited by the Th1-inducing adjuvant IL-12. Strikingly, schistosome-infected C57BL/6 and BALB/c IL-13Rα2–deficient mice showed a marked exacerbation in hepatic fibrosis, despite displaying no change in granuloma size, tissue eosinophilia, or mastocytosis. Fibrosis increased despite the fact that IL-13 levels decreased significantly in the liver and serum. Importantly, pathology was prevented when IL-13Rα2–deficient mice were treated with a soluble IL-13Rα2-Fc construct, formally demonstrating that their exacerbated fibrotic response was due to heightened IL-13 activity. Together, these studies illustrate the central role played by the IL-13Rα2 in the down-regulation of a chronic and pathogenic Th2-mediated immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Self-citationRequirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Self-citationOpal, S. M., & DePalo, V. A. (2000) · Chest · doi:10.1378/chest.117.4.1162 · Cited by 1,752
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Stat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,628
Self-citationThe IL-4 receptor: signaling mechanisms and biologic functions
Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., & Paul, W. E. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.701 · Cited by 1,545 · cited 2×
“The PCR cycles used for each cytokine were as follows: IL-13 (33), IL-4 (34), IL-5 (31), IFN- (29), IL-13R 1 (28), IL-13R 2 (30), IL4R 1 (27), c chain (27), and hypoxanthine-guanine phosphoribosyl transferase (HPRT; reference 23).”
BackgroundMethodTwo Improved and Simplified Methods for the Spectrophotometric Determination of Hydroxyproline.
Bergman, I., & Loxley, R. (1963) · Analytical Chemistry · doi:10.1021/ac60205a053 · Cited by 1,525
Interleukin-2 Receptor γ Chain: a Functional Component of the Interleukin-7 Receptor
Noguchi, M., Nakamura, Y., Russell, S. M., Ziegler, S. F., Tsang, M., Cao, X., & Leonard, W. J. (1993) · Science · doi:10.1126/science.8266077 · Cited by 1,109
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S. K., Sims, J. E., & Mantovani, A. (1993) · Science · doi:10.1126/science.8332913 · Cited by 980
Recombinant human interleukin 5 is a selective activator of human eosinophil function.
Lopez, A. F., Sanderson, C. J., Gamble, J. R., Campbell, H. D., Young, I. G., & Vadas, M. A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.1.219 · Cited by 951
Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
Gazzinelli, R. T., Wysocka, M., Hieny, S., Scharton-Kersten, T., Cheever, A., Kühn, R., Müller, W., Trinchieri, G., & Sher, A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.798 · Cited by 927
Self-citationThe germless theory of allergic disease: revisiting the hygiene hypothesis
Wills-Karp, M., Santeliz, J., & Karp, C. L. (2001) · Nature Reviews Immunology · doi:10.1038/35095579 · Cited by 788
Hesse, M., Modolell, M., La Flamme, A. C., Schito, M., Fuentes, J. M., Cheever, A. W., Pearce, E. J., & Wynn, T. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6533 · Cited by 706
Self-citationAdvanced multiplexed analysis with the FlowMetrix system.
Fulton, R. J., McDade, R. L., Smith, P. L., Kienker, L. J., & Kettman, J. R. (1997) · PubMed · Cited by 704
NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway
Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D. D., Carbone, D. P., Paul, W. E., & Berzofsky, J. A. (2000) · Nature Immunology · doi:10.1038/82771 · Cited by 699
Self-citationAdvanced multiplexed analysis with the FlowMetrixTM system
Fulton, R. J., McDade, R. L., Smith, P. L., Kienker, L. J., & Kettman, J. R. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.9.1749 · Cited by 650
Interleukin-2 Receptor γ Chain: a Functional Component of the Interleukin-4 Receptor
Russell, S. M., Keegan, A. D., Harada, N., Nakamura, Y., Noguchi, M., Leland, P., Friedmann, M. C., Miyajima, A., Puri, R. K., Paul, W. E., et al. (1993) · Science · doi:10.1126/science.8266078 · Cited by 605
Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W., & Wynn, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7325 · Cited by 603
Self-citationUrban, J. F., Noben-Trauth, N., Donaldson, D. D., Madden, K. B., Morris, S. C., Collins, M., & Finkelman, F. D. (1998) · Immunity · doi:10.1016/s1074-7613(00)80477-x · Cited by 580
Self-citationModolell, M., Corraliza, I. M., Link, F., Soler, G., & Eichmann, K. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250436 · Cited by 554
Grzych, J. M., Pearce, E., Cheever, A., Caulada, Z. A., Caspar, P., Heiny, S., Lewis, F., & Sher, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.4.1322 · Cited by 542
Self-citationHoffmann, K. F., Cheever, A. W., & Wynn, T. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6406 · Cited by 473
Self-citationActivation of hepatic stellate cells - a key issue in liver fibrosis
Reeves, H. (2002) · Frontiers in Bioscience · doi:10.2741/reeves · Cited by 423
Amiri, P., Locksley, R. M., Parslow, T. G., Sadickt, M., Rector, E., Ritter, D., & McKerrow, J. H. (1992) · Nature · doi:10.1038/356604a0 · Cited by 419
An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection
Wynn, T. A., Cheever, A. W., Jankovic, D., Poindexter, R. W., Caspar, P., Lewis, F. A., & Sher, A. (1995) · Nature · doi:10.1038/376594a0 · Cited by 403
Self-citationFallon, P. G., Richardson, E. J., McKenzie, G. J., & McKenzie, A. N. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2585 · Cited by 403
Hilton, D. J., Zhang, J. G., Metcalf, D., Alexander, W. S., Nicola, N. A., & Willson, T. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.497 · Cited by 401
Critical Role for IL-13 in the Development of Allergen-Induced Airway Hyperreactivity
Walter, D. M., McIntire, J. J., Berry, G., McKenzie, A. N. J., Donaldson, D. D., DeKruyff, R. H., & Umetsu, D. T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4668 · Cited by 396
Self-citationA distinct role for interleukin-13 in Th2-cell-mediated immune responses
McKenzie, G. J., Bancroft, A., Grencis, R. K., & McKenzie, A. N. J. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70134-4 · Cited by 385
Finkelman, F. D., Madden, K. B., Morris, S. C., Holmes, J. M., Boiani, N., Katona, I. M., & Maliszewski, C. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1235 · Cited by 366
IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi
Hunter, C. A., Ellis-Neyes, L. A., Slifer, T., Kanaly, S., Grünig, G., Fort, M., Rennick, D., & Araujo, F. G. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.7.3311 · Cited by 352
Wynn, T. A., Eltoum, I., Cheever, A. W., Lewis, F. A., Gause, W. C., & Sher, A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1430 · Cited by 330
Self-citationDonaldson, D. D., Whitters, M. J., Fitz, L. J., Neben, T. Y., Finnerty, H. F., Henderson, S. L., O'Hara, R. M., Beier, D. R., Turner, K. J., Wood, C. R., et al. (1998) · PubMed · Cited by 321
Self-citationShi, Z., Wakil, A. E., & Rockey, D. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10663 · Cited by 310
Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.
Hasegawa, M., Fujimoto, M., Kikuchi, K., & Takehara, K. (1997) · PubMed · Cited by 308
Lanone, S., Zheng, T., Zhu, Z., Liu, W., Lee, C. G., Ma, B., Chen, Q., Homer, R. J., Wang, J., Rabach, L. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14136 · Cited by 299
Häyry, P., Isoniemi, H., Yilmaz, S., Mennander, A., Lemström, K., Räisänen‐Sokolowski, A., Koskinen, P., Ustinov, J., Lautenschlager, I., Taskinen, E., et al. (1993) · Immunological Reviews · doi:10.1111/j.1600-065x.1993.tb00639.x · Cited by 290
A Critical Role for IL-13 in Resistance to Intestinal Nematode Infection
Bancroft, A. J., McKenzie, A. N. J., & Grencis, R. K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3453 · Cited by 287
Donaldson, D. D., Whitters, M. J., Fitz, L. J., Neben, T. Y., Finnerty, H., Henderson, S. L., O’Hara, R. M., Beier, D. R., Turner, K. J., Wood, C. R., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2317 · Cited by 277
Self-citationCheever, A. W., Williams, M. E., Wynn, T. A., Finkelman, F. D., Seder, R. A., Cox, T. M., Hieny, S., Caspar, P., & Sher, A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.2.753 · Cited by 275
Self-citationCaput, D., Laurent, P., Kaghad, M., Lelias, J.-M., Lefort, S., Vita, N., & Ferrara, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16921 · Cited by 274
IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis
Brunet, L. R., Finkelman, F. D., Cheever, A. W., Kopf, M. A., & Pearce, E. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.2.777 · Cited by 271
Self-citationWynn, T. A., Eltoum, I., Oswald, I. P., Cheever, A. W., & Sher, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1551 · Cited by 266
Self-citationLanone, S., Zheng, T., Zhu, Z., Liu, W., Lee, C. G., Ma, B., Chen, Q., Homer, R. J., Wang, J., Rabach, L. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214136 · Cited by 248
Th2 Cells Are Required for the Schistosoma mansoni Egg-Induced Granulomatous Response
Kaplan, M. H., Whitfield, J. R., Boros, D. L., & Grusby, M. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1850 · Cited by 225
Self-citationKawakami, K., Taguchi, J., Murata, T., & Puri, R. K. (2001) · Blood · doi:10.1182/blood.v97.9.2673 · Cited by 218
Chiaramonte, M. G., Schopf, L. R., Neben, T. Y., Cheever, A. W., Donaldson, D. D., & Wynn, T. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.920 · Cited by 214
Self-citationMiloux, B., Laurent, P., Bonnin, O., Lupker, J., Caput, D., Vita, N., & Ferrara, P. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01462-7 · Cited by 214
Wallace, W. A. H., Ramage, E. A., Lamb, D., & Howie, S. E. M. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03131.x · Cited by 200
Enhanced Interleukin (IL)-13 Responses in Mice Lacking IL-13 Receptor α 2
Wood, N., Whitters, M. J., Jacobson, B. A., Witek, J., Sypek, J. P., Kasaian, M., Eppihimer, M. J., Unger, M., Tanaka, T., Goldman, S. J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020906 · Cited by 184
Self-citationChiaramonte, M. G., Cheever, A. W., Malley, J. D., Donaldson, D. D., & Wynn, T. A. (2001) · Hepatology · doi:10.1053/jhep.2001.26376 · Cited by 174
Self-citationCytokine regulation of granuloma formation in schistosomiasis
Wynn, T. A., & Cheever, A. W. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80095-6 · Cited by 156
Self-citationIdentification, Purification, and Characterization of a Soluble Interleukin (IL)-13-binding Protein
Zhang, J., Hilton, D. J., Willson, T. A., McFarlane, C., Roberts, B., Moritz, R. L., Simpson, R. J., Alexander, W. S., Metcalf, D., & Nicola, N. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9474 · Cited by 149
Jankovic, D. L., Kullberg, M. C., Noben-Trauth, N., Caspar, P., Ward, J. M., Cheever, A. W., Paul, W. E., & Sher, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.337 · Cited by 149
Self-citationStructure of and signal transduction through interleukin-4 and interleukin-13 receptors (review).
Murata, T., Obiri, N. I., & Puri, R. K. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.1.3.551 · Cited by 135
Hoffmann, K. F., James, S. L., Cheever, A. W., & Wynn, T. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.927 · Cited by 132
Self-citationFinkelman, F. D., Wynn, T. A., Donaldson, D. D., & Urban, J. F. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80070-3 · Cited by 128
Self-citationShirwan, H. (1999) · Transplantation · doi:10.1097/00007890-199909270-00001 · Cited by 127
Vaillant, B. D., Chiaramonte, M. G., Cheever, A. W., Soloway, P. D., & Wynn, T. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.7017 · Cited by 124
Self-citationWynn, T. A., Morawetz, R., Scharton‐Kersten, T., Hieny, S. E., Morse, H. C., Kühn, R., Müller, W., Cheever, A. W., & Sher, A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.5014 · Cited by 120
Self-citationHesse, M., Cheever, A. W., Jankovic, D. L., & Wynn, T. A. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64607-x · Cited by 117
Self-citationSchistosoma mansoni in IL-4-deficient mice
Pearce, E. J., Cheever, A. W., Leonard, S., Covalesky, M., Fernandez-Botrán, R., Köhler, G., & Köpf, M. (1996) · International Immunology · doi:10.1093/intimm/8.4.435 · Cited by 117
Self-citationDevelopment of an assay to measure in vivo cytokine production in the mouse
Finkelman, F. D., & Morris, S. C. (1999) · International Immunology · doi:10.1093/intimm/11.11.1811 · Cited by 106
Hoffmann, K. F., McCarty, T. C., Segal, D., Chiaramonte, M. G., Hesse, M., Davis, E. M., Cheever, A. W., Meltzer, P. S., Morse, H. C., & Wynn, T. A. (2001) · The FASEB Journal · doi:10.1096/fj.01-0306fje · Cited by 104
Self-citationA Novel Mechanism by Which Interferon-γ Can Regulate Interleukin (IL)-13 Responses
Daines, M., & Hershey, G. K. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108109200 · Cited by 94
Majumdar, S., Li, D., Ansari, T. W., Pantelidis, P., Black, C. M., Gizycki, M. J., du Bois, R. M., & Jeffery, P. K. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14b03.x · Cited by 86
Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat
WESTERMANN, R. S. W. (1999) · International Journal of Radiation Biology · doi:10.1080/095530099140276 · Cited by 82
Feng, N., Lugli, S. M., Schnyder, B., Gauchat, J., Graber, P., Schlagenhauf, E., Schnarr, B., Wiederkehr-Adam, M., Duschl, A., Heim, M. H., et al. (1998) · PubMed · Cited by 75
Baecher‐Allan, C., & Barth, R. K. (1993) · PubMed · Cited by 59
Fallon, P. G., Richardson, E. J., Smith, P., & Dunne, D. W. (2000) · European Journal of Immunology · Cited by 56
IL-13-Mediated Worm Expulsion Is B7 Independent and IFN-γ Sensitive
Urban, J. F., Fang, H., Liu, Q., Ekkens, M. J., Chen, S.-J., Nguyen, D. N., Mitro, V., Donaldson, D. D., Byrd, C., Peach, R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4250 · Cited by 48
Self-citationEffects of IL-13 on airway responses in the guinea pig
Morse, B. W., Sypek, J. P., Donaldson, D. D., Haley, K. J., & Lilly, C. M. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00296.2001 · Cited by 32
Self-citation
Cited by
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Self-citationAlternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
“The profibrotic activity of IL-13 is controlled by the abundance of the IL-13R α 1 signaling receptor and IL-13R α 2 decoy receptor expressed on important target cells such as myofibroblasts 90,91 .”
Self-citationFibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Self-citation
Metadata
- Authors
- Chiaramonte, M. G., Mentink-Kane, M., Jacobson, B. A., Cheever, A. W., Whitters, M. J., Goad, M. E. P., Wong, A., Collins, M., Donaldson, D. D., Grusby, M. J., & Wynn, T. A.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-03-17
- Volume
- 197
- Issue
- 6
- Pages
- 687-701
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2164262821
- Cited by
- 258
- References
- 73
- FWCI
- 15.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.